Atrial fibrillation
KEYWORDS: fibrillation, atrial, atrial fibrillation, adults, quality, adults atrial, anticoagulation, data, statement, stroke, nice, source, local, risk, quality statement

above are offered anticoagulation. Adults with a type of atrial fibrillation called 'non-valvular' who are identified by their doctor as being at higher risk of having a stroke are offered treatment with a medicine called an anticoagulant, to lower their risk of having a blood clot that could cause a stroke. Source guidance Atrial fibrillation: diagnosis and management. NICE guideline 196 (2021), recommendation 1.6.3 Definitions of terms used in this quality statement CHA DS -VASc stroke risk score 2 2 The CHA DS -VASc stroke risk score estimates the risk of stroke in people with 2 2 non-valvular atrial fibrillation. [Adapted from NICE's guideline on atrial fibrillation, recommendations 1.2.1 and 1.6.3] Bleeding risk score Bleeding risk, estimated using ORBIT bleeding risk score, should be taken into account when offering anticoagulation. The ORBIT bleeding risk score estimates the risk of bleeding. Although ORBIT is the best tool for this purpose, other bleeding risk tools may need to be used until it is embedded in clinical pathways and electronic systems. [Adapted from NICE's guideline on atrial fibrillation, recommendation 1.2.2] Quality statement 2: Use of aspirin Quality statement Adults with atrial fibrillation are not prescribed aspirin as monotherapy for stroke prevention. Rationale The
